Senate race shows how hard it is to run on abortion in the heartland; Editas' turnaround hinges on key drug updates

A relatively one-sided race in Missouri demonstrates that abortion alone may not be enough to sway voters in America's heartland. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Sponsored by   Missouri Senate race shows just how hard it is to campaign on abortion in the heartland By Nicholas Florko Michael M. Santiago/Getty Images A relatively one-sided race in Missouri demonstrates that abortion alone may not be enough to sway voters in America's heartland. Read More STAT+: A turnaround for Editas Medicine, a CRISPR laggard, hinges on updates on key treatments By Adam Feuerstein and Damian Garde Ruby Wallau for STAT Other CRISPR companies command multibillion-dollar valuations, but Editas trades below its IPO price following upheaval and clinical delay. Read More STAT+: Novel solution to biotech's market valuation woes: Just give the cash back By Jason Mast and Adam Feuerstein PATRICK T. FALLON/AFP via Getty Images The request, made by Apeiron Investment of the biotech Sensei Biotherapeutics, is a bold response to an industry-wide problem. Read More Sponsored Insight by Boston Scientific Finding the needle in the haystack: Using data-driven insight to address health disparities Advocating for greater health equity has become the work of every self-respecting healthcare institution. Now, asks one scientist and health equity leader: What exactly is that work? What steps can we take toward meaningful change? The answers, she writes, is in the data. Her team is mining healthcare data in smart ways to pinpoint specific, actionable gaps – and, she suggests, the entire medtech industry is positioned to help. Read more. STAT+: Physicians rally to avert Medicare payment cuts By Bob Herman Adobe The government is reducing Medicare payments to physicians next year by 4.5%, but they're ready to blitz Congress to avert the cuts. Read More Opinion: Listen: Will opioid settlement money actually go to opioid prevention? Here's hoping By Patrick Skerrett As states begin to receive money from national opioid settlements, they may not be spending it on efforts that work to prevent addiction. Read More STAT+: Medicare punts on quality rules for new type of rural hospital By Tara Bannow Adobe Hospitals that convert to Medicare’s new rural designation won’t have to report quality data next year, the agency said this week. Read More CVS, Walgreens announce opioid settlements totaling $10B By Geoff Mulvihill — Associated Press Justin Sullivan/Getty Image The developments could be the last round of huge settlements after years of litigation over the drug industry's role in the overdose epidemic. Read More Opinion: Give Americans the right to save on health care By Jonathan Wolfson and Josh Archambault Adobe The Patient's Right to Save Act would ensure that insurers won't penalize people for saving money with a cash-based option. Read More Wednesday, November 2, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser